Efficacy of pastes containing CPP-ACP and CPP-ACFP in patients with Sjogren's syndrome
Authorized Users Only
2015
Authors
Perić, Tamara
Marković, Dejan

Petrović, Bojan
Radojević, Vesna J.

Todorović, Tatjana
Anđelski-Radičević, Biljana
Jančić-Heinemann, Radmila M.

Susić, Gordana
Peri'-Popadić, Aleksandra
Tomić-Spirić, Vesna

Article (Published version)

Metadata
Show full item recordAbstract
The purpose of this study was to evaluate efficacy of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) and casein phosphopeptide-amorphous calcium fluoride phosphate (CPP-ACFP) containing pastes among individuals with Sjogren's syndrome (SS). Thirty patients were randomised into three groups: CPP-ACP, CPP-ACFP, and 0.05 % NaF to be used two times a day during a 28-day experimental period. Saliva was analysed for flow rate, pH, buffering capacity and mineral concentrations. Dental plaque was examined for pH. Following the formation of artificial carious lesion, participants wore enamel slabs for an in situ remineralisation study. Remineralisation potential was examined using scanning electron microscope (SEM) and energy dispersive spectroscopic (EDS) technique. SE microphotographs were subsequently analysed for area, diameter, perimeter, roundness and the number of enamel defects and percentage of tooth surface affected by defects. At the end of the experimental period, a sli...ght increase of salivary pH could have been observed. No differences in mineral composition of saliva were noted. The use of CPP-ACP and CPP-ACFP contributed to a significant rise of plaque pH. Image analysis revealed excessive reduction of defects' dimensions in the three experimental groups, and a decrease of the number of enamel defects in the CPP-ACP and CPP-ACFP groups. The EDS analysis did not show differences in Ca/P, Ca/O and P/O ratios in any of the treatment groups. CPP-ACP and CPP-ACFP hold promise as remineralising agents for patients with SS. Pastes containing CPP-ACP/CPP-ACFP show enhanced remineralisation potential compared with NaF mouthrinse in patients with SS.
Keywords:
Casein phosphopeptide-amorphous calcium phosphate / Casein phosphopeptide-amorphous calcium fluoride phosphate / Sjogren's syndrome / Saliva / Dental plaque / Enamel remineralisationSource:
Clinical Oral Investigations, 2015, 19, 9, 2153-2165Publisher:
- Springer Heidelberg, Heidelberg
DOI: 10.1007/s00784-015-1444-1
ISSN: 1432-6981
PubMed: 25762499
WoS: 000365519800001
Scopus: 2-s2.0-84948113270
Collections
Institution/Community
Stomatološki fakultetTY - JOUR AU - Perić, Tamara AU - Marković, Dejan AU - Petrović, Bojan AU - Radojević, Vesna J. AU - Todorović, Tatjana AU - Anđelski-Radičević, Biljana AU - Jančić-Heinemann, Radmila M. AU - Susić, Gordana AU - Peri'-Popadić, Aleksandra AU - Tomić-Spirić, Vesna PY - 2015 UR - https://smile.stomf.bg.ac.rs/handle/123456789/1998 AB - The purpose of this study was to evaluate efficacy of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) and casein phosphopeptide-amorphous calcium fluoride phosphate (CPP-ACFP) containing pastes among individuals with Sjogren's syndrome (SS). Thirty patients were randomised into three groups: CPP-ACP, CPP-ACFP, and 0.05 % NaF to be used two times a day during a 28-day experimental period. Saliva was analysed for flow rate, pH, buffering capacity and mineral concentrations. Dental plaque was examined for pH. Following the formation of artificial carious lesion, participants wore enamel slabs for an in situ remineralisation study. Remineralisation potential was examined using scanning electron microscope (SEM) and energy dispersive spectroscopic (EDS) technique. SE microphotographs were subsequently analysed for area, diameter, perimeter, roundness and the number of enamel defects and percentage of tooth surface affected by defects. At the end of the experimental period, a slight increase of salivary pH could have been observed. No differences in mineral composition of saliva were noted. The use of CPP-ACP and CPP-ACFP contributed to a significant rise of plaque pH. Image analysis revealed excessive reduction of defects' dimensions in the three experimental groups, and a decrease of the number of enamel defects in the CPP-ACP and CPP-ACFP groups. The EDS analysis did not show differences in Ca/P, Ca/O and P/O ratios in any of the treatment groups. CPP-ACP and CPP-ACFP hold promise as remineralising agents for patients with SS. Pastes containing CPP-ACP/CPP-ACFP show enhanced remineralisation potential compared with NaF mouthrinse in patients with SS. PB - Springer Heidelberg, Heidelberg T2 - Clinical Oral Investigations T1 - Efficacy of pastes containing CPP-ACP and CPP-ACFP in patients with Sjogren's syndrome VL - 19 IS - 9 SP - 2153 EP - 2165 DO - 10.1007/s00784-015-1444-1 ER -
@article{ author = "Perić, Tamara and Marković, Dejan and Petrović, Bojan and Radojević, Vesna J. and Todorović, Tatjana and Anđelski-Radičević, Biljana and Jančić-Heinemann, Radmila M. and Susić, Gordana and Peri'-Popadić, Aleksandra and Tomić-Spirić, Vesna", year = "2015", abstract = "The purpose of this study was to evaluate efficacy of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) and casein phosphopeptide-amorphous calcium fluoride phosphate (CPP-ACFP) containing pastes among individuals with Sjogren's syndrome (SS). Thirty patients were randomised into three groups: CPP-ACP, CPP-ACFP, and 0.05 % NaF to be used two times a day during a 28-day experimental period. Saliva was analysed for flow rate, pH, buffering capacity and mineral concentrations. Dental plaque was examined for pH. Following the formation of artificial carious lesion, participants wore enamel slabs for an in situ remineralisation study. Remineralisation potential was examined using scanning electron microscope (SEM) and energy dispersive spectroscopic (EDS) technique. SE microphotographs were subsequently analysed for area, diameter, perimeter, roundness and the number of enamel defects and percentage of tooth surface affected by defects. At the end of the experimental period, a slight increase of salivary pH could have been observed. No differences in mineral composition of saliva were noted. The use of CPP-ACP and CPP-ACFP contributed to a significant rise of plaque pH. Image analysis revealed excessive reduction of defects' dimensions in the three experimental groups, and a decrease of the number of enamel defects in the CPP-ACP and CPP-ACFP groups. The EDS analysis did not show differences in Ca/P, Ca/O and P/O ratios in any of the treatment groups. CPP-ACP and CPP-ACFP hold promise as remineralising agents for patients with SS. Pastes containing CPP-ACP/CPP-ACFP show enhanced remineralisation potential compared with NaF mouthrinse in patients with SS.", publisher = "Springer Heidelberg, Heidelberg", journal = "Clinical Oral Investigations", title = "Efficacy of pastes containing CPP-ACP and CPP-ACFP in patients with Sjogren's syndrome", volume = "19", number = "9", pages = "2153-2165", doi = "10.1007/s00784-015-1444-1" }
Perić, T., Marković, D., Petrović, B., Radojević, V. J., Todorović, T., Anđelski-Radičević, B., Jančić-Heinemann, R. M., Susić, G., Peri'-Popadić, A.,& Tomić-Spirić, V.. (2015). Efficacy of pastes containing CPP-ACP and CPP-ACFP in patients with Sjogren's syndrome. in Clinical Oral Investigations Springer Heidelberg, Heidelberg., 19(9), 2153-2165. https://doi.org/10.1007/s00784-015-1444-1
Perić T, Marković D, Petrović B, Radojević VJ, Todorović T, Anđelski-Radičević B, Jančić-Heinemann RM, Susić G, Peri'-Popadić A, Tomić-Spirić V. Efficacy of pastes containing CPP-ACP and CPP-ACFP in patients with Sjogren's syndrome. in Clinical Oral Investigations. 2015;19(9):2153-2165. doi:10.1007/s00784-015-1444-1 .
Perić, Tamara, Marković, Dejan, Petrović, Bojan, Radojević, Vesna J., Todorović, Tatjana, Anđelski-Radičević, Biljana, Jančić-Heinemann, Radmila M., Susić, Gordana, Peri'-Popadić, Aleksandra, Tomić-Spirić, Vesna, "Efficacy of pastes containing CPP-ACP and CPP-ACFP in patients with Sjogren's syndrome" in Clinical Oral Investigations, 19, no. 9 (2015):2153-2165, https://doi.org/10.1007/s00784-015-1444-1 . .